Cargando…
HOW TO TREAT PATIENTS AFTER SERIOUS ADVERSE EFFECTS CAUSED BY TNF INHIBITORS?
Biological agents are widely used in the treatment of autoimmune rheumatic disorders. We report on serious adverse events during treatment with anti-tumor necrosis factor antibody in two of our patients with juvenile idiopathic arthritis. One patient was treated with a biological agent due to juveni...
Autores principales: | Sršen, Saša, Marušić, Eugenija, Metličić, Vitomir, Stričević, Luka, Frković, Marijan, Jelušić, Marija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382877/ https://www.ncbi.nlm.nih.gov/pubmed/32724288 http://dx.doi.org/10.20471/acc.2020.59.01.20 |
Ejemplares similares
-
COMPARISON OF DIFFERENT DIAGNOSTIC GUIDELINES FOR THE DIAGNOSIS OF MACROPHAGE ACTIVATION SYNDROME COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTRE EXPERIENCE
por: Jelušić, Marija, et al.
Publicado: (2018) -
Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014) -
Successful use of adalimumab as a conservative treatment for bilateral knee lipoma arborescens in patient with psoriatic juvenile idiopathic arthritis – case report and review of literature
por: Frkovic, Marijan, et al.
Publicado: (2022) -
Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis
por: Sestan, Mario, et al.
Publicado: (2021) -
SUCCESSFULLY TREATED ACUTE INTERSTITIAL PNEUMONIA
por: Gomerčić Palčić, Marija, et al.
Publicado: (2022)